The Immunopathologic Effects of Mycoplasma pneumoniae and Community-acquired Respiratory Distress Syndrome Toxin. A Primate Model
- PMID: 28915064
- PMCID: PMC5805996
- DOI: 10.1165/rcmb.2017-0006OC
The Immunopathologic Effects of Mycoplasma pneumoniae and Community-acquired Respiratory Distress Syndrome Toxin. A Primate Model
Abstract
Mycoplasma pneumoniae infection has been linked to poor asthma outcomes. M. pneumoniae produces an ADP-ribosylating and vacuolating toxin called community-acquired respiratory distress syndrome (CARDS) toxin that has a major role in inflammation and airway dysfunction. The objective was to evaluate the immunopathological effects in primates exposed to M. pneumoniae or CARDS toxin. A total of 13 baboons were exposed to M. pneumoniae or CARDS toxin. At Days 7 and 14, BAL fluid was collected and analyzed for cell count, percent of each type of cell, CARDS toxin by PCR, CARDS toxin by antigen capture, eosinophilic cationic protein, and cytokine profiles. Serum IgM, IgG, and IgE responses to CARDS toxin were measured. All animals had a necropsy for analysis of the histopathological changes on lungs. No animal developed signs of infection. The serological responses to CARDS toxin were variable. At Day 14, four of seven animals exposed to M. pneumoniae and all four animals exposed to CARDS toxin developed histological "asthma-like" changes. T cell intracellular cytokine analysis revealed an increasing ratio of IL-4/IFN-γ over time. Both M. pneumoniae and CARDS toxin exposure resulted in similar histopathological pulmonary changes, suggesting that CARDS toxin plays a major role in the inflammatory response.
Keywords: asthma; community-acquired respiratory distress syndrome toxin; mycoplasma; primate model.
Figures



Similar articles
-
Mycoplasma pneumoniae CARDS toxin exacerbates ovalbumin-induced asthma-like inflammation in BALB/c mice.PLoS One. 2014 Jul 24;9(7):e102613. doi: 10.1371/journal.pone.0102613. eCollection 2014. PLoS One. 2014. PMID: 25058417 Free PMC article.
-
Mycoplasma pneumoniae CARDS toxin elicits a functional IgE response in Balb/c mice.PLoS One. 2017 Feb 15;12(2):e0172447. doi: 10.1371/journal.pone.0172447. eCollection 2017. PLoS One. 2017. PMID: 28199385 Free PMC article.
-
Mycoplasma pneumoniae Community Acquired Respiratory Distress Syndrome toxin expression reveals growth phase and infection-dependent regulation.Mol Microbiol. 2010 Jun 1;76(5):1127-41. doi: 10.1111/j.1365-2958.2010.07092.x. Epub 2010 Feb 28. Mol Microbiol. 2010. PMID: 20199607 Free PMC article.
-
Exploring the pathogenicity of Mycoplasma pneumoniae: Focus on community-acquired respiratory distress syndrome toxins.Microb Pathog. 2024 Oct;195:106865. doi: 10.1016/j.micpath.2024.106865. Epub 2024 Aug 15. Microb Pathog. 2024. PMID: 39153578 Review.
-
Pathogenesis of Mycoplasma pneumoniae: An update.Indian J Med Microbiol. 2016 Jan-Mar;34(1):7-16. doi: 10.4103/0255-0857.174112. Indian J Med Microbiol. 2016. PMID: 26776112 Review.
Cited by
-
D-dimer: The Risk Factor of Children's Severe Mycoplasma Pneumoniae Pneumonia.Front Pediatr. 2022 Apr 12;10:828437. doi: 10.3389/fped.2022.828437. eCollection 2022. Front Pediatr. 2022. PMID: 35498793 Free PMC article.
-
Anti-human Interleukin(IL)-4 Clone 8D4-8 Cross-Reacts With Myosin-9 Associated With Apoptotic Cells and Should Not Be Used for Flow Cytometry Applications Querying IL-4 Expression.Front Cell Dev Biol. 2019 Apr 9;7:46. doi: 10.3389/fcell.2019.00046. eCollection 2019. Front Cell Dev Biol. 2019. PMID: 31024909 Free PMC article.
-
Observational retrospective clinical study on clinical features of macrolide-resistant Mycoplasma pneumoniae pneumonia in Chinese pediatric cases.Sci Rep. 2024 Mar 7;14(1):5632. doi: 10.1038/s41598-024-55311-2. Sci Rep. 2024. PMID: 38453960 Free PMC article.
-
Clinical characteristics and risk factors for Mycoplasma pneumoniae pneumonia in children.Front Pediatr. 2024 Dec 23;12:1438631. doi: 10.3389/fped.2024.1438631. eCollection 2024. Front Pediatr. 2024. PMID: 39764167 Free PMC article.
-
Outcomes of Adjunctive Corticosteroid Treatment in Hypoxemic Adults Hospitalized for Mycoplasma pneumoniae Pneumonia: A Retrospective Cohort Study.Clin Infect Dis. 2025 Feb 24;80(2):454-460. doi: 10.1093/cid/ciae451. Clin Infect Dis. 2025. PMID: 39230949 Free PMC article.
References
-
- Sembajwe G, Cifuentes M, Tak SW, Kriebel D, Gore R, Punnett L. National income, self-reported wheezing and asthma diagnosis from the World Health Survey. Eur Respir J. 2010;35:279–286. - PubMed
-
- Global Initiative for Asthma. Global strategy for asthma management and prevention. 2016 [accessed 2016 Dec 1]. Available from: http://ginasthma.org/2016-gina.
-
- Berkovich S, Millian SJ, Snyder RD. The association of viral and mycoplasma infections with recurrence of wheezing in the asthmatic child. Ann Allergy. 1970;28:43–49. - PubMed
-
- Seggev JS, Lis I, Siman-Tov R, Gutman R, Abu-Samara H, Schey G, et al. Mycoplasma pneumoniae is a frequent cause of exacerbation of bronchial asthma in adults. Ann Allergy. 1986;57:263–265. - PubMed
-
- Lieberman D, Lieberman D, Printz S, Ben-Yaakov M, Lazarovich Z, Ohana B, et al. Atypical pathogen infection in adults with acute exacerbation of bronchial asthma. Am J Respir Crit Care Med. 2003;167:406–410. - PubMed
Publication types
MeSH terms
Substances
Grants and funding
LinkOut - more resources
Full Text Sources
Other Literature Sources
Medical